Background: The Selective Cytopheretic Device (SCD) is an immunomodulatory cell-directed extracorporeal therapy that reprograms activated neutrophils and monocytes towards immune homeostasis in hyperi
Note: Compared with control,**P*PHematological parameters (mean ± standard deviation) in female rats intragastrically administered Ah daily for 14 consecutive days.